田辺三菱製薬 臨床試験情報サイト
を離れます。よろしいですか?
(別ウィンドウが開きます)
We are leaving the Mitsubishi Tanabe Pharma Clinical Trial Information Site.
(A new window will be opened.)
Mitsubishi Tanabe Pharma Clinical Trial Information Site
The information on this web site is intended for the disclosure of clinical trial information for Mitsubishi Tanabe Pharma Corporation (Hereinafter referred to as MTPC). It is not intended for promotion or advertisement of MTPC medicinal products. Also, it is not intended to recommend off-label use nor unapproved use of any products. And it does not replace any doctor’s decision. If you have any questions about individual symptoms and treatment strategies, please consult with your doctor(s) or appropriate healthcare professionals.
MTPC strives to provide the most up-to-date information about all clinical trials included here. Please note that the clinical trial status, etc. will be updated as appropriate.
In order to provide information on clinical trials to patients, healthcare professionals, researchers, and others, MTPC posts clinical trial information on public registries. The registries provide clinical trial information such as a summary of the clinical trials, the target diseases, and the status of the clinical trials.
The clinical trial information made available on the public registries are available in the “List of Summaries of Clinical Trial Information”.
MTPC is committed to disclose clinical trial results that are available to patients, healthcare professionals, researchers, and others. MTPC is also preparing to disclose a summary of results that are easy to understand for patients and the public.
MTPC will endeavor to provide relevant presentations at scientific meetings, or publications in scientific journals of the clinical trial results where results are considered of significant medical importance at an appropriate time. When such an article is published, MTPC will post the place of publication on public registries.
The results of the clinical trials are available in the “List of Summaries of Clinical Trial Information”.
For questions regarding disclosure of clinical trial information, please email us: